Literature DB >> 14725991

Ossifying fibromyxoid tumor of the ethmoid sinus in a newborn: report of a case and literature review.

Khalid A Al-Mazrou1, Atiya Mansoor, Misty Payne, Mark A Richardson.   

Abstract

Ossifying fibromyxoid tumor (OFT) of soft parts is a benign soft tissue tumor commonly located in the extremities. In this paper, a 3-week-old boy presented with left nasal mass at birth. He was found to have an OFT involving the ethmoid sinus. To the best of our knowledge, this is the first reported case of OFT in a newborn with involvement of the sinuses. This rare tumor should alert Pediatric Otolaryngologists to include it in the differential diagnosis of pediatric soft tissue tumors in sinuses.

Entities:  

Mesh:

Year:  2004        PMID: 14725991     DOI: 10.1016/j.ijporl.2003.09.016

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Ossifying fibromyxoid tumour: a rare soft tissue tumour of intermediate malignancy.

Authors:  F Binesh; A Akhavan; H Navabii
Journal:  BMJ Case Rep       Date:  2011-03-24

2.  Ossifying fibroma of the ethmoid sinus: Report of a rare case and review of literature.

Authors:  Zhaleh Mohsenifar; Saeedallah Nouhi; Fatemeh Mashhadi Abbas; Sareh Farhadi; Behzad Abedin
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

3.  Malignant ossifying fibromyxoid tumor of the calvaria: illustrative case.

Authors:  Jan T Hachmann; R Scott Graham
Journal:  J Neurosurg Case Lessons       Date:  2021-08-23

Review 4.  Endonasal endoscopic resection of ossifying fibroma involving the ethmoid sinus, orbit and anterior skull base: case report and literature review.

Authors:  M Jurlina; N Skitarelić; D Passali; F M Passali; R Mladina
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-04-29       Impact factor: 2.124

Review 5.  Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.

Authors:  Ignacio A Velasco; Ran Zhang; Tiejun Li; Diancan Wang
Journal:  Diagn Pathol       Date:  2018-03-27       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.